High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset, clinical trial finds
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in doses of 100,000 IU every two weeks significantly reduced disease activity in clinically isolated ...
